Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Schneck

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Discovery Medicine|August 14, 2010
Immunotherapy with enhanced self immune cellsMathias Oelke, Jonathan Schneck
Journal of Immunological Methods|April 21, 2009
Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cellsTakayuki Shiratsuchi, Jonathan Schneck, Akira Kawamura, et al.
Biophysical Journal|December 4, 2012
Modulation of MHC binding by lateral association of TCR and coreceptorKarlo Perica, Joan Glick Bieler, Michael Edidin, et al.
Rambam Maimonides Medical Journal|February 27, 2015
Adoptive T cell immunotherapy for cancerKarlo Perica, Juan Carlos Varela, Mathias Oelke, et al.
Bio-Protocol|June 10, 2016
Generation of Mouse iNKT Cell LinesXiangming Li, Moriya Tsuji, Jonathan Schneck, et al.
Bio-Protocol|August 30, 2016
Generation of Human iNKT Cell LinesXiangming Li, Moriya Tsuji, Jonathan Schneck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Ascites specific inhibition of CD1d-mediated activation of natural killer T cellsTonya J Webb, Robert L Giuntoli, Ophelia Rogers, et al.
Nature Medicine|July 3, 2007
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerSrinivas Nagaraj, Kapil Gupta, Vladimir Pisarev, et al.
Cancer Immunology Research|November 29, 2017
Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T CellsNils-Petter Rudqvist, Karsten A Pilones, Claire Lhuillier, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2013
Nanoscale artificial antigen presenting cells for T cell immunotherapyKarlo Perica, Andrés De León Medero, Malarvizhi Durai, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Discovery Medicine|August 14, 2010
Immunotherapy with enhanced self immune cellsMathias Oelke, Jonathan Schneck
Journal of Immunological Methods|April 21, 2009
Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cellsTakayuki Shiratsuchi, Jonathan Schneck, Akira Kawamura, et al.
Biophysical Journal|December 4, 2012
Modulation of MHC binding by lateral association of TCR and coreceptorKarlo Perica, Joan Glick Bieler, Michael Edidin, et al.
Rambam Maimonides Medical Journal|February 27, 2015
Adoptive T cell immunotherapy for cancerKarlo Perica, Juan Carlos Varela, Mathias Oelke, et al.
Bio-Protocol|June 10, 2016
Generation of Mouse iNKT Cell LinesXiangming Li, Moriya Tsuji, Jonathan Schneck, et al.
Bio-Protocol|August 30, 2016
Generation of Human iNKT Cell LinesXiangming Li, Moriya Tsuji, Jonathan Schneck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Ascites specific inhibition of CD1d-mediated activation of natural killer T cellsTonya J Webb, Robert L Giuntoli, Ophelia Rogers, et al.
Nature Medicine|July 3, 2007
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerSrinivas Nagaraj, Kapil Gupta, Vladimir Pisarev, et al.
Cancer Immunology Research|November 29, 2017
Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T CellsNils-Petter Rudqvist, Karsten A Pilones, Claire Lhuillier, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2013
Nanoscale artificial antigen presenting cells for T cell immunotherapyKarlo Perica, Andrés De León Medero, Malarvizhi Durai, et al.
Pageof 2